BRTX News Alert Biorestorative Therapies Inc (BRTX) 0.3198 09/27/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biorestorative Therapies Inc (BRTX) 0.3198 $BRTX

BioRestorative Therapies Announces Relocation To New York State
Business Wire - Wed Sep 03, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced it has been awarded up to $500,000 in performance-based Excelsior Tax Credits from Empire State Development ("ESD" , New York State's economic development agency, as part of a relocation incentive package from the State, as well an estimated $146,000 of sales tax exemptions and property tax abatement from the Suffolk County Industrial Development Agency ("IDA" .

BioRestorative Therapies Engages Consulting Firm to Develop Strategic Partnerships in Japan and China
Business Wire - Mon Aug 18, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced the engagement of Tokyo-based Solution Partners Ltd. to develop strategic alliances in Japan and China for the Company's technologies. The agreement includes introductions to potential strategic partners and other alliance candidates, with the goal of expansion and development of the Company's ThermoStem(R) program, the Company's stem cell delivery device used in connection with the Company's brtx-DISC(TM) program and the Company's brtx-C Cosmetic program.

BioRestorative Therapies Issues Letter to Stockholders
Business Wire - Mon Jul 14, 7:01AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, has issued a letter to stockholders, the text of which is below.

BioRestorative Therapies Appoints Joseph B. Swiader to its Board of Directors
Business Wire - Wed Jul 02, 7:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the appointment of Joseph B. Swiader, age 54, to its Board of Directors. Mr. Swiader will chair the Nominating Committee and serve on the Compensation Committee of the Board.

BioRestorative Therapies Appoints The Honorable Paul Jude Tonna to its Board of Directors
Business Wire - Mon Jun 30, 7:01AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the appointment of The Honorable Paul Jude Tonna to its Board of Directors. Mr. Tonna will serve on the Audit, Compensation and Nominating committees of the Board.

BioRestorative Therapies Signs Research and Development Agreement with Rohto Pharmaceutical
Business Wire - Tue Mar 25, 8:42AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a Research and Development Agreement ("Agreement" with Rohto Pharmaceutical Company, Ltd. ("Rohto" . Under the Agreement, BRT has been engaged to provide stem cell research and development services.

BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine
Business Wire - Mon Mar 03, 7:30AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a consulting agreement with Gregory Lutz, M.D. pursuant to which Dr. Lutz will serve as Chief Medical Advisor for Spine Medicine.

HMG Strategy Presents The 2014 CIO Summit of America - A Gathering of Global Executives in New York City
PR Newswire - Tue Jan 14, 12:54PM CST
HMG Strategy, the leading producer of CIO Executive Leadership Summits in North America, in partnership with the NY Metro Chapter of the Society for Information Management, will host the renowned CIO Summit of America on January 28, 2014 at The Harvard Club of New York City.

BioRestorative Therapies' Brown Fat Stem Cells Research Published in February Issue of Stem Cells Journal
Business Wire - Tue Jan 14, 10:51AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that a preclinical study that is part of its ThermoStem(R) program has been published in the February issue of the peer-reviewed journal, Stem Cells. A photograph of the Company's brown fat stem cell scaffold appears prominently on the cover. As previously announced, the newly identified human adult brown fat stem cells discussed in the study have the potential to lead to the development of a cell-based method for the treatment of type 2 diabetes and obesity.

OTC Daily Alert Stock Watch - BioRestorative Therapies, Inc. (OTCQB: BRTX)
WorldStockWire - Thu Aug 15, 8:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

BioRestorative Therapies Receives Approval to Conduct Retrospective Safety Study on its Bulging/Herniated Disc Procedure
PR Newswire - Tue Aug 06, 6:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications, today announced that it has received approval from the Western Institutional Review Board ("the Board" to complete a retrospective safety study on selected subjects previously treated by the Company's brtxDISC(TM) bulging and herniated disc procedure. The study is titled "Re-consenting and Follow-Up of Adults from a Retrospective Study Using Autologous Transplantation of Marrow Derived Mesenchymal Stem Cells to Degenerated Intervertebral Disc."

BioRestorative Therapies Provides Company Updates with Shareholder Letter
PR Newswire - Thu Aug 01, 7:51AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on stem cell-based therapeutics, today announced the issuance of a shareholder letter by Chief Executive Officer, Mark Weinreb, providing an update to shareholders on the Company's progress.

BioRestorative Therapies CEO Mark Weinreb Interviewed by The Life Sciences Report
Marketwire - Thu Jul 25, 1:01PM CDT
"Millions of people suffer back pain caused by herniated and bulging disc disease. When conventional medical therapies fail, they often resort to surgery for relief, a costly and time-consuming solution for both patients and the medical system. In this interview with The Life Sciences Report, Mark Weinreb, president, CEO and chairman of BioRestorative Therapies Inc. (OTCQB: BRTX), describes how his company's cell therapy process could keep disc disease treatment out of the operating theater.

BioRestorative Therapies Expands its ThermoStem® Program to 150 Stem Cell Lines
PR Newswire - Mon Jun 24, 7:19AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on stem cell-based therapeutics, announced that it has expanded its ThermoStem® Program by collecting 150 samples of human brown adipose tissue (BAT). For the past year, through strategic collaboration and internal BRT efforts, the Company has grown a large library of human brown fat stem cells. The ThermoStem® Program, which is in the pre-clinical stage, focuses on the development of therapies using adult derived stem cells from brown adipose tissue to treat metabolic and obesity related disorders (particularly focusing on Type 2 Diabetes). The compilation of a large number and variety of brown fat derived stem cells allows BRT to study and identify potential cell lines to be used in developing therapies.

BioRestorative Therapies CEO Mark Weinreb Interviewed on "Next Big Thing" with Financial Personality and Founder Tobin Smith
PR Newswire - Mon Jun 17, 7:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX) - Financial personality and Founder of NBT Equities Research, Tobin Smith, recently interviewed BioRestorative Therapies, Inc. (the "Company" CEO, Mark Weinreb, on the firm's hybrid business model and what the firm is currently doing that will help change the biotechnology landscape. BioRestorative is a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications.

BioRestorative Therapies Announces the Development of an Extract that has Promise for Use in Beauty Care Products
PR Newswire - Wed May 29, 6:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications, today announced that it has developed a human cellular-derived extract that, per initial in vitro studies, when applied to skin cells, appears to cause a significant increase in collagen and fibronectin production (proteins that are essential for combating the aging of skin). BRT plans to conduct additional in vitro studies to better understand the extract's mechanism of action and human cellular activity.

BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference
PR Newswire - Tue May 21, 6:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announced that Mark Weinreb, its President and CEO, will be presenting at the Marcum MicroCap Conference.

BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC(TM) Stem Cell Therapy Device
PR Newswire - Mon May 20, 7:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announces the signing of a consulting agreement with Dexterity, Inc. ("Dexterity" . Dexterity is a product design and bioengineering firm that will provide services to further the development and production of BRT's proprietary therapeutic delivery device for its intervertebral disc stem cell therapy program, "brtxDISC(TM)," (Disc Implanted Stem Cells).

BioRestorative Therapies Invited to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria
PR Newswire - Tue Apr 16, 9:25AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell based cellular therapies for various personal medical applications, announced today that it has been invited to present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria. The conference will take place April 18th-20th, 2013 at the Austria Center Vienna and will highlight early interventions for diabetes, dysglycemia, and surgery in the treatment of obesity and diabetes, where world leaders and specialists will discuss pioneering research in these areas.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 225

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 321

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 391

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 342

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Partnership Boosts Clinical Trials with AI Insights

Updated Category News Views 138

Transforming Clinical Trials Through AI Collaboration In a groundbreaking announcement, NetraMark Holdings Inc. (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an innovative leader in artificial intelligence, has entered into a significant partnership with Pentara Corporation, a trusted name in the pharmaceutical data analytics sector. This collaboration aims to...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 414

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
Minerals Technologies Enhances Pet Care Operations for Future Growth

Updated Category News Views 95

Minerals Technologies' Strategic Expansion in Pet Care Sector Minerals Technologies Inc. (NYSE: MTX) is making substantial strides to expand its operations in the pet care sector, particularly focusing on its SIVO™ brand of cat litter. This global leader in specialty minerals is undergoing transformative upgrades in its facilities across various countries, responding to...

Continue Reading
Insight into Latest Trading Activities of Treatt plc

Updated Category News Views 194

Key Information about Treatt plc Trading FORM 8.5 (EPT/RI) Public Disclosure by an Exempt Principal Trader in Client-Serving Capacity Rule 8.5 of the Takeover Code (the "Code") Essential Details (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree related to this form: Treatt plc (c) Connection of Exempt Principal Trader t

Continue Reading
Breeze Holdings Forms Strategic Alliance with YD Biopharma

Updated Category News Views 87

Breeze Holdings and YD Biopharma Unite Breeze Holdings Acquisition Corp. is thrilled to share an important milestone in its journey. The company has reached a definitive agreement to merge with YD Biopharma Limited. This isn't just any business deal; it marks a significant move toward advancements in cancer prevention and diagnostics. Discovering YD Biopharma's Purpose YD...

Continue Reading